Loading people...
Arthur Bourgade is a Senior Associate at Seventure Partners based in Paris, France. He joined the venture capital firm, which manages over €900 million in assets, as an Analyst in January 2019 before being promoted to his current role in early 2024. Within the firm's Life Sciences team, he analyzes investment opportunities, conducts due diligence, and manages portfolio participations across Europe, North America, and Asia. Prior to entering venture capital, he completed consulting internships focused on health strategy and private equity due diligence at Antares Consulting and CMI Stratégies. His academic credentials include an engineering master's degree in life sciences from AgroParisTech and a double master's degree in finance and strategy from Sciences Po. Bourgade currently leverages his dual expertise in biological engineering and finance to evaluate emerging startups within the life sciences and sportech sectors.
Arthur Bourgade is a dedicated Analyst at Seventure Partners, a well-established venture capital firm renowned for its significant contributions to the European innovation ecosystem. In his pivotal role, Arthur is deeply involved in the intricate process of sourcing and assessing potential investment opportunities, particularly within the dynamic fields of technology and life sciences. His analytical acumen is instrumental in supporting Seventure Partners' mission to back groundbreaking companies from their early stages.
At Seventure Partners, Arthur's responsibilities encompass a broad spectrum of activities essential to venture capital investment. He conducts thorough market research to identify emerging trends and disruptive technologies, performs in-depth financial analysis and valuation of prospective portfolio companies, and assists in comprehensive due diligence processes. This involves scrutinizing business models, management teams, competitive landscapes, and intellectual property to ensure sound investment decisions. His contributions are vital in preparing detailed investment memos and presentations for the firm's partners and investment committee.
Seventure Partners has a strong track record in both digital technologies and life sciences, including areas like digital health, biotech, medtech, and sustainable innovation. Arthur Bourgade's work directly supports these strategic investment areas, helping the firm to identify companies with high growth potential and significant market impact. While specific individual investments are typically attributed to the firm's overall portfolio, Arthur's analytical support is fundamental to the success of many of Seventure's early stage ventures.
Arthur's career background reflects a strong foundation in finance and a keen interest in innovation, positioning him perfectly for his role in venture capital. Professionals in his position often bring expertise from investment banking, consulting, or prior startup experience, coupled with a robust understanding of financial modeling and market dynamics. This background enables him to critically evaluate complex business propositions and contribute effectively to the investment team's strategic discussions.
His role as an Analyst is crucial for Seventure Partners' continued success in identifying and nurturing the next generation of industry leaders. Arthur Bourgade's commitment to rigorous analysis and his passion for supporting innovative enterprises underscore his value to the firm and its portfolio companies, helping to drive growth and foster technological advancements across Europe and beyond.
Arthur Bourgade is an Analyst at Seventure Partners, a leading European venture capital firm. He specializes in evaluating early stage investment opportunities, primarily in the technology and life sciences sectors.
As an Analyst at Seventure Partners, Arthur Bourgade contributes to investments in early stage companies across technology and life sciences. This includes areas like digital health, biotech, medtech, and sustainable innovation, aligning with the firm's strategic focus.
Arthur Bourgade works at Seventure Partners, a prominent venture capital firm with a strong presence in the European innovation landscape. The firm is known for its investments in digital technologies and life sciences.